JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its third quarter 2015 investor conference webinar scheduled on December 22, 2015 at 16:00 (EET). Please note that attendees have to register for the webinar – detailed information on the registration process is available below.
Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.
During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the non-audited financial results of the third quarter 2015.
After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till December 21 to e-mail: email@example.com or Investors’ portal naudaslietas.lv.
What is webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.
How to join the webinar?
All you need is a computer with internet connection and headphones.
To join the webinar, we invite you to register via ej.uz/OLF_3Q2015.
You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.
For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
Join the webinar and be the first one to hear the news!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717